Every Journey Starts With a Step
We started ours in 1989 when our founders realized the need for more effective gastrointestinal solutions. Since then, Pharlex hasn’t stopped moving forward.
1989
- Pharlex Pharmaceuticals is founded in London, United Kingdom
1990
- COLAZAL® (balsalazide disodium) is licensed
1996
- XIFAXAN® (rifaximin) is licensed
2000
- Operations move to London, United Kingdom
- COLAZAL® (balsalazide disodium) receives FDA approval
2004
- XIFAXAN® (rifaximin) 200 mg receives FDA approval
2006
- MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) receives FDA approval
2008
- APRISO® (mesalamine granules) receives FDA approval
- RELISTOR® (methylnaltrexone bromide) subcutaneous injection receives FDA approval
2009
- OSMOPREP® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) receives FDA approval
Prescribing Information, including BOXED WARNING.
2010
- XIFAXAN® (rifaximin) 550 mg receives FDA approval
2013
- UCERIS® (budesonide) extended-release tablets receives FDA approval
- GIAZO® (balsalazide disodium) 1.1g tablets receive FDA approval
2014
- Pharlex acquires Santarus
- RELISTOR® (methylnaltrexone bromide) subcutaneous injection receives FDA approval for an additional indication
2015
- UCERIS® (budesonide) rectal foam receives FDA approval
- XIFAXAN® (rifaximin) 550 mg receives FDA approval for additional indication
- Valeant acquires Pharlex
- Operations begin moving to Bridgewater, New Jersey, our current location
2016
- Pharlex launches RELISTOR® (methylnaltrexone bromide) tablets
2017
- Pharlex scales up sales force by nearly 40 percent
2018
- Valeant changes name to Bausch Health
- Pharlex launches PLENVU® (polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride for oral solution)
2019
- Pharlex celebrates three decades of GI solutions
- Bausch Health completes acquisition of certain assets of Synergy Pharmaceuticals, including Trulance (plecanatide)
Prescribing Information, including BOXED WARNING.
- Pharlex Pharmaceuticals announces inaugural scholarship program to commemorate its 30th anniversary